Interim Impact: The Rise of “Fractional” Medical Affairs Roles in Pharma’s New Reality

In this episode, Tom Caravela and Daniel Snyder explore the rise of fractional medical affairs roles in the post-COVID era. They define interim and fractional positions, highlighting how they benefit both job seekers and companies. The discussion covers the increase in these roles, company utilization of interim talent, disadvantages, and compensation expectations, offering negotiation tips for candidates. They also discuss the future of fractional staffing, market trends, and the gig economy's impact on pharma and biotech. The episode ends with cost-effective strategies and gratitude to the audience.

(0:00) Welcome, guest introduction, and topic introduction: Rise of fractional medical affairs roles
(0:41) Announcements: Fierce Pharma Week and Aspire MSL program anniversary
(2:41) Defining interim and fractional roles in medical affairs
(5:06) Reasons for the rise in fractional positions post-COVID and how companies utilize interim talent
(12:44) Bridging the gap with fractional roles for job seekers and advantages for companies
(22:29) Disadvantages and compensation expectations for fractional roles
(30:12) Negotiation strategies for fractional staffing
(32:39) Future of fractional staffing in pharma and biotech, market trends, and impact
(35:12) Cost-effective strategies and the rise of the gig economy in pharma and biotech
(37:06) Closing remarks, gratitude, and call to action